Power Law company profile

Roivant Sciences

Biotech & Life Sciences · New York City, United States · Founded 2014 Decacorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$15B

Market cap · Apr/2026

Revenue

$29M

Latest reported FY

Investors

9 investors on Roivant Sciences's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 9 investors entered at this stage

QVT Financial LP

NovaQuest Capital Management

SoftBank Vision Fund

Viking Global Investors

Global footprint

Where Roivant Sciences has talent and traffic

AI talent share

0.4% of workforce is AI talent
(1 of 228 staff)

Core AI00%

Other AI10.44%

Non-AI workforce22799.56%

Web traffic by country

19K monthly visits
across markets

🇺🇸 United States60%

🇬🇧 United Kingdom13.7%

🇯🇵 Japan8.9%

🇫🇷 France7.4%

🇮🇳 India6.8%

Top 5 markets shown

Patent intelligence

$28M patent portfolio · 25 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value

$28M

0.18% of market cap · 3.6× smaller than top peer Celltrion ($101M)

25 active patent families

Where Roivant Sciences innovates Pharmaceutical drugDiseasePharmacologyTetrahydrothiophenePyridazine

Tech-focus vs peers

Where Roivant Sciences concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Roivant Sciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Roivant Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo